Earnings call ASP Isotopes delivered a transformative Q3 2025, with radiopharmaceutical revenue up 18% YoY and three enrichment plants operational. Management reaffirmed 2026 revenue visibility and ...

PLMA's annual Salute to Excellence Awards program recognizes outstanding food and nonfood products introduced within the last year. The winning products are on display at PLMA's 2025 "Store Brands ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Thomas J Catalano is a CFP and Registered Investment Adviser with ...

TPG Telecom has confirmed a customer in Sydney died last week after a mobile phone could not make Triple Zero calls. The telco says early investigations indicated the failed calls were due to a ...

The median net worth in the U.S. is $192,900, according to the Federal Reserve's 2022 Survey of Consumer Finances, a 37% increase from 2019. Americans approaching retirement have an even larger nest ...

When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) or a placebo, patients who received TXA needed significantly fewer blood ...

Storing and syncing files in the cloud makes your life easier and keeps your data safer. The top cloud storage services we've tested let you easily share and access files from anywhere and restore ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

The best USB-C hubs add ports to your PC, providing connections to legacy peripherals like mice, keyboards, printers, or more. If you follow my advice, you shouldn’t pay that much, either. The very ...

JPMorgan Short Duration Core Plus Fund earns an Above Average Process Pillar rating. The main contributor to the rating is the fund's impressive long-term risk-adjusted performance. This can be seen ...

ORLANDO — In this video, Shazia K. Nakhoda, MD, discusses “exciting” data from the CLL-17 trial that showed fixed-duration therapy produces similar results inpreviously untreated chronic lymphocytic ...